1. Home
  2. ZH vs RZLT Comparison

ZH vs RZLT Comparison

Compare ZH & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zhihu Inc. (every two of each representing one ordinary share)

ZH

Zhihu Inc. (every two of each representing one ordinary share)

HOLD

Current Price

$3.78

Market Cap

283.6M

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$3.37

Market Cap

326.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZH
RZLT
Founded
2011
2010
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
283.6M
326.4M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
ZH
RZLT
Price
$3.78
$3.37
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$9.67
AVG Volume (30 Days)
508.6K
2.4M
Earning Date
05-26-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.32
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$20.74
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.57
$1.07
52 Week High
$5.55
$11.46

Technical Indicators

Market Signals
Indicator
ZH
RZLT
Relative Strength Index (RSI) 70.51 53.11
Support Level $3.22 $2.87
Resistance Level $4.53 $3.73
Average True Range (ATR) 0.19 0.22
MACD 0.10 0.02
Stochastic Oscillator 91.53 53.24

Price Performance

Historical Comparison
ZH
RZLT

About ZH Zhihu Inc. (every two of each representing one ordinary share)

Zhihu Inc is predominantly engaged in the operation of one online content community and monetizes through paid membership services, advertising services, content-commerce solutions services, and vocational training in China. It generates revenues from Advertising services, Paid membership services, Content-commerce solutions, and Others. It derives all its revenues within China.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: